CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Coherus Biosciences, Inc.  (CHRS)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
 

CHRS's Revenue Year on Year Growth by Quarter and Year

Coherus Biosciences,'s Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
CHRS Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 162.84 7.17 16.05
III Quarter September - 14.07 6.87 0.00
II Quarter June 1.40 12.36 5.81 0.00
I Quarter March 0.16 10.20 -46.09 0.00
FY   1.56 199.47 -26.24 16.05

Financial Statements
Coherus Biosciences,'s second quarter 2017 Revenue $ 1.40 millions CHRS's Income Statement
Coherus Biosciences,'s second quarter 2016 Revenue $ 12.36 millions Quarterly CHRS's Income Statement
CHRS's Growth by Division See CHRS's Growth by Segment

CHRS Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - 2171.13 % -55.33 % -
III Quarter September - 104.8 % - -
II Quarter June -88.71 % 112.74 % - -
I Quarter March -98.43 % - - -
FY   - - - -



CHRS Revenue Growth Comment
Coherus Biosciences, Inc. reported drop in Revenue in the second quarter by -88.71% to $ 1.40 millions, from the same quarter in 2016.
The fall in the second quarter Coherus Biosciences, Inc.'s Revenue compares unfavorably to the Company's average Revenue doubling of 357.58%.

Looking into second quarter results within Biotechnology & Drugs industry 93 other companies have achieved higher Revenue growth. While Coherus Biosciences, Inc.' s Revenue meltdown of -88.71% ranks overall at the positon no. 3639 in the second quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #94
Healthcare Sector #456
Overall #3639
Revenue Y/Y Growth Statistics
High Average Low
2172.01 % 357.58 % -98.7 %
(Sep 30 2016)   (Mar 31 2017)

You need to upgrade your Flash Player

Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CHRS's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for CHRS's Competitors
Revenue Growth for Coherus Biosciences,'s Suppliers
Revenue Growth for CHRS's Customers

You may also want to know
CHRS's Annual Growth Rates CHRS's Profitability Ratios CHRS's Asset Turnover Ratio CHRS's Dividend Growth
CHRS's Roe CHRS's Valuation Ratios CHRS's Financial Strength Ratios CHRS's Dividend Payout Ratio
CHRS's Roa CHRS's Inventory Turnover Ratio CHRS's Growth Rates CHRS's Dividend Comparisons



Companies with similar Revenue meltdown for the quarter ending Jun 30 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2017
Fate Therapeutics Inc -0.10 %$ -0.097 millions
Psychemedics Corp -0.17 %$ -0.165 millions
Halyard Health, Inc. -0.20 %$ -0.200 millions
Xtant Medical Holdings, Inc. -0.25 %$ -0.249 millions
Ocular Therapeutix, Inc. -0.68 %$ -0.680 millions
Emergent Biosolutions Inc. -0.70 %$ -0.705 millions
Tenet Healthcare Corp -0.90 %$ -0.900 millions
Integrated Biopharma Inc -1.21 %$ -1.212 millions
Genmark Diagnostics, Inc. -1.22 %$ -1.223 millions
Trovagene, Inc. -1.34 %$ -1.343 millions
Mymetics Corp -1.86 %$ -1.858 millions
Vaso Corp -1.98 %$ -1.982 millions
Recro Pharma, Inc. -2.00 %$ -1.997 millions
Inc Research Holdings, Inc. -2.13 %$ -2.130 millions
Quorum Health Corporation -2.16 %$ -2.165 millions
China Biologic Products Holdings, Inc. -2.34 %$ -2.344 millions
Msa Safety Incorporated -2.44 %$ -2.440 millions
Pacific Biosciences Of California, Inc. -3.25 %$ -3.249 millions
T2 Biosystems, Inc. -3.43 %$ -3.434 millions
Therapeuticsmd, Inc. -3.47 %$ -3.470 millions
Harvard Bioscience Inc -3.53 %$ -3.532 millions
Twinlab Consolidated Holdings, Inc. -3.61 %$ -3.614 millions
Acceleron Pharma Inc -4.32 %$ -4.319 millions
Conformis Inc -4.39 %$ -4.391 millions
Lifevantage Corp -4.51 %$ -4.510 millions
Endologix Inc -4.74 %$ -4.744 millions
Steris Plc -4.76 %$ -4.764 millions
China Senior Living Industry International Holding -4.88 %$ -4.883 millions
Becton Dickinson & Co -5.10 %$ -5.097 millions
Cancer Genetics, Inc -5.67 %$ -5.671 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SMRT's Profile

Stock Price

SMRT's Financials

SMRT's Expectations

Business Description

Fundamentals

Charts & Quotes

SMRT's News

Suppliers

SMRT's Competitors

Customers & Markets

Economic Indicators

SMRT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com